NATURAL NEUROTROPIC AUTOANTIBODIES IN BLOOD SERUM OF EPILEPSY PATIENTS

Cover Page

Abstract


Background: The purpose of research was to determine the level of natural neurotropic autoantibodies in blood serum of patients with idiopathic and symptomatic epilepsies. Patients and methods: 43 epilepsy patients (27 males and 16 females) at the age of from 16 till 70 years (average age 43,1±1,02 years) were studied — 11 patients with idiopathic epilepsy (group I) and 32 patients with symptomatic epilepsy (group II). By the method of immunoenzymatic analysis and original idiotype-antiidiotype test-system ELI-N-Test (Russia) in blood serum of the patients the levels of autoantibodies (aAB) to brain proteins-antigens (NF-200, GFAP, MBP and S100β) and to receptors of neuromediators (glutamate, GABA, dopamine, serotonin and choline-receptors) we determined. Results: All groups of epilepsy patients differed from control group by as individual levels, as degree of deviations of the studied immunological parameters. Serum levels of neurotropic aAB to NF-200, GFAP, MBP and S100β, as well as to receptors of neuromediators (glutamate, GABA, dopamine, serotonin and choline-receptors) were noted to increase. The features of immune disturbances depended on the form and severity of epilepsy. Conclusion: Autoimmune processes have the certain place in the pathogenesis of epilepsy. The degree and duration of increase in the levels of neurotropic aAB have the prognostic significance for the evaluation severity degree of epilepsy course that could be an additional criterion in the integrated diagnosis and timely correction of treatment for epilepsy.


About the authors

Kh. A. Rasulova

Tashkent Pediatric Medical Institute

Author for correspondence.
Email: khurshidakhon@gmail.com

Uzbekistan MD, Head of the Department (Laboratory) of Research management and external doctorate student of the Department of Neurology, child neurology with course of clinical genetics of Tashkent Pediatric Medical Institute, Secretary-General of Uzbekistan League Against Epilepsy

R.B. Arizova

Tashkent Medical Academy, Uzbekistan

Email: bahodirovna1983@mail.ru

Uzbekistan

starshii nauchnyi sotrudnik-soiskatel’ kafedry nervnykh boleznei Tashkentskoi meditsinskoi aka-demii
Address: 2, Farobi Street, Tashkent, Republic of Uzbekistan, 100109

References

  1. Epileptologiya detskogo vozrasta: Ruk-vo dlya vrachei. Pod red. A.S. Petrukhina [Child Epileptology: Guideline.Edited by A.S. Petrushkin. Illustrated]. Moscow, Meditsina, 2000. 624 p.
  2. Epidemiology. Epilepsy: safety, excess mortality and sudden death. In: European White Paper on Epilepsy. M.J. Brodie, H.M. DeBoer, S.I. Joannessen (eds). Epilepsia. 2003; 44 (Suppl. 6): 17–20.
  3. Gekht A.B. Zhurn. nevrol. i psikhiatrii = Journal of neurology and psychiatry. 2005; 11: 66–67.
  4. Rakhimbaeva G.S., Prokhorova A.V., Tuichibaeva N.M. Sovremennye aspekty diagnostiki epilepsii i printsipy ratsional'noi antiepilepticheskoi terapii. Metod. rekomendats. dlya prakt. vrachei [Current Aspects of Diagnosis and Principles of Rational Therapy Against Epilepsy. Methodological Recommendations for Practicing Doctors]. Tashkent, 2009. 44 p.
  5. Gafurov B.G., Madzhidova Ya.N., Gafurov Sh.B. Razvitie epileptologii v Uzbekistane i voprosy okazaniya prakticheskoi pomoshchi bol'nym epilepsiei. V kn.: Sovremennaya epileptologiya. Pod red. E.I. Guseva, A.B. Gekht [Development of Epileptology in Uzbekistan and Problems of Medical Care of Epileptic. In the book: Current Epileptology. Edited by E.I. Gusev, A.B. Gekht]. St. Petersburg, 2011. pp. 571–575.
  6. Rasulova Kh.A. Nevrologiya = Neurology. 2009; 4: 54–59.
  7. Vetrile L.A., Evseev V.A., Karpova M.N. Vestnik RAMN = Annals of RAMS. 2004; 8: 43–46.
  8. Kryzhanovskii G.N., Magaeva S.V., Makarov S.V., Sepiashvili R.I. Neiroimmunopatologiya. Ruk-vo [Neuroimmunopathology. Manual]. Moscow, 2003. 438 p.
  9. Lusnikova I.V. Klinicheskie i neiroimmunologicheskie aspekty farmakorezistentnoi epilepsii. Avtoref. dis. … kand. med. nauk [Clinical and Neuroimmunological Characteristics of Intractable Epilepsy. Author’s abstract]. Moscow, 2008. 32 p.
  10. Malashkhiya V.Yu. Zhurn. nevrol. i psikhiatrii = Journal of neurology and psychiatry. 1996; 2: 18–20.
  11. Gusev E.I., Guekht A.B., Poletaev A.В., Lusnikova I.V., Feygina A.A., Kovaleva I.U. Сhanges of serum levels of natural neurotropic autoantibodies in patients with partial symptomatic/cryptogenic epilepsy. Epilepsia. 2006; 47 (Suppl. 3): 38.
  12. Dzugaeva F.K. Kliniko-immunologicheskie, biokhimicheskie kriterii i prognoz partsial'noi epilepsii. Avtoref. dis. … dokt. med. nauk [Clinical, Immunological and Biochemical Characteristics and Prognosis of Cortical Epilepsy. Author’s abstract]. Moscow, 2004. 32 p.
  13. Zin'kovskii K.A. Kliniko-patokhimicheskie, immunologicheskie izmeneniya i ikh terapevticheskaya korrektsiya u bol'nykh epilepsiei. Avtoref. dis. … kand. med. nauk [Clinical, Immunological and Pathochemical Changes and its Therapeutic Correction in Children. Author’s abstract]. Moscow, 2004. 30 p.
  14. Morozov S.G., Gnedenko B.B., Asanova L.M. Zhurn. nevrol. i psikhiatrii = Journal of neurology and psychiatry. 1996; 4: 71–74.
  15. Mantegazza R., Bernasconi P., Baggi F., Spreafico R., Ragona F., Antozzi C., Bernardi G., Granata T. Antibodies against GluR3 peptides are not specific for Rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. Neuroimmunology. 2002; 131 (1–2): 179–185.
  16. Peltola J., Kulmala P., Isojarvi J., Saiz A., Latvala K., Palmio J., Savola K., Knip M., Keranen T., Graus F. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology. 2000; 55 (1): 46–50.
  17. Asanova L.M., Morozov S.G., Yakovlev H.A., Zin'kovskii K.A. Neiroimmunologiya = Neuroimmunology. 2003; 1(2): 57–58.
  18. Poletaev A.B., Alferova V.V., Abrosimova A.A., Komissarova I.A., Sokolov M.A., Gusev E.I. Neiroimmunologiya = Neuroimmunology. 2003; 1(1): 11–17.
  19. Poletaev A.B., Abrosimova A.A., A.A., Socolov M.A., Gekht A.B., A.B., Alferova V.V., Gusev E.I., Nicolaeva T.Ya. Dialectics and implications of natural neurotropic autoantibodies in neurological disease and rehabilitation. Clin. & Dev. Immunol. 2004; 11 (2): 151–156.
  20. Commission on Classification and Terminology of the International League Against Epilepsy, Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989; 30: 796–803.
  21. Engel J.J. ILAE classification of epilepsy syndromes. Epilepsia. 2006; 70: 5–10.
  22. Vincent A., Honnorat J., Antoine J.C., Giometto B., Dalmau J., Lang B. Autoimmunity in paraneoplastic neurological disorders. Neuroimmunology. 1998; 84 (1): 105–109.
  23. Prokhorova A.V. Zhurn. teor. i klin. meditsiny = Journal of theoretical and clinical medicine. 2011; 5: 64–67.
  24. Aarli J.A. Immunological aspects of epilepsy. Brain Dev. 1993; 15 (1): 41–49.
  25. Weissberg I., Reichert A., Heinemann U., Friedman A. Blood-brain barrier dysfunction in epileptogenesis of the temporal lobe. Epilepsy Res. Treat. 2011; 143908: doi: 10.1155/2011/143908.
  26. Gulyaeva N.V. Neirokhimiya = Neurochemistry. 2010; 2: 102–108.
  27. Gannushkina I.V., Lebedeva N.V. Gipertonicheskaya entsefalopatiya [Hypertensive Encephalopathy]. Moscow, Meditsina, 1987. 224 p.

Statistics

Views

Abstract - 279

PDF (Russian) - 226

Cited-By


PlumX

Dimensions



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies